Kosten der Schizophrenie: Strukturgleichungsmodelle als Instrument der Entscheidungshilfe bei gesundheitsökonomischen Fragestellungen

Research output: Contribution to journalArticleResearchpeer review

Authors

  • J. Clouth
  • A. Uber
  • J. M. Graf von der Schulenburg

External Research Organisations

  • Eli Lilly and Company
View graph of relations

Details

Translated title of the contributionCosts of schizphrenia - Structural equation models as decision making support tool in health economics: Structural Equation Models as Decision Making Support Tool in Health Economics
Original languageMultiple languages
Pages (from-to)120-124
Number of pages5
JournalGesundheitsokonomie und Qualitatsmanagement
Volume8
Issue number2
Publication statusPublished - Apr 2003
Externally publishedYes

Abstract

Objective: The goal of the study is to bring out advantages of structural equation models over conventional methods in health economic decision-making processes. Methods: In this study, causal relations of direct and indirect costs are investigated in schizophrenic subjects. The structural equation models are based on data obtained from a health care analysis. X2 test, degrees of freedom, P value, goodness of fit and adjusted goodness of fit are used to evaluate the structural equation models. Results: The structural equation model demonstrates that no less than 23 percent of direct costs for the treatment of schizophrenia are accounted for by the two factors severity of disease and time. The severity of disease carries more weight than the time factor. The standardized path coefficient is 0.33. The time factor has less effect than the severity of disease with a standardized regression coefficient of 0.27. The double arrow between the factors severity and time describes a correlation which is 0.26. Based on both inference statistical and descriptive parameters, all of which are within the nominal range, the structural equation model for direct costs can be confirmed with the data set on hand. With use of this model, 51 percent of indirect costs are accounted for by the two factors severity and time. As for indirect costs, the time factor of 0.63 carries more than twice as much weight as severity exerting effects with a standardized path coefficient of 0.25. This also explains the correlation between the residuum of the Global Assessment Scale (GAS) and the residuum of the time factor. There is a relationship between the residuum of GAS, which measures the degree of severity in the long term, and the residuum of the time factor. It may be conjectured that another factor is hiding behind this correlation, that is early retirement. In this model, too, all parameters are within the nominal range. Conclusions: The example of costs of schizophrenia has demonstrated the portrayal and quantification of networking structures. Due to the portrayal of structures and quantification of causal relationships, structural equation models provide substantial support for decision-making processes.

ASJC Scopus subject areas

Sustainable Development Goals

Cite this

Kosten der Schizophrenie: Strukturgleichungsmodelle als Instrument der Entscheidungshilfe bei gesundheitsökonomischen Fragestellungen. / Clouth, J.; Uber, A.; Graf von der Schulenburg, J. M.
In: Gesundheitsokonomie und Qualitatsmanagement, Vol. 8, No. 2, 04.2003, p. 120-124.

Research output: Contribution to journalArticleResearchpeer review

Clouth, J, Uber, A & Graf von der Schulenburg, JM 2003, 'Kosten der Schizophrenie: Strukturgleichungsmodelle als Instrument der Entscheidungshilfe bei gesundheitsökonomischen Fragestellungen', Gesundheitsokonomie und Qualitatsmanagement, vol. 8, no. 2, pp. 120-124. https://doi.org/10.1055/s-2003-39145
Clouth, J., Uber, A., & Graf von der Schulenburg, J. M. (2003). Kosten der Schizophrenie: Strukturgleichungsmodelle als Instrument der Entscheidungshilfe bei gesundheitsökonomischen Fragestellungen. Gesundheitsokonomie und Qualitatsmanagement, 8(2), 120-124. https://doi.org/10.1055/s-2003-39145
Clouth J, Uber A, Graf von der Schulenburg JM. Kosten der Schizophrenie: Strukturgleichungsmodelle als Instrument der Entscheidungshilfe bei gesundheitsökonomischen Fragestellungen. Gesundheitsokonomie und Qualitatsmanagement. 2003 Apr;8(2):120-124. doi: 10.1055/s-2003-39145
Clouth, J. ; Uber, A. ; Graf von der Schulenburg, J. M. / Kosten der Schizophrenie : Strukturgleichungsmodelle als Instrument der Entscheidungshilfe bei gesundheitsökonomischen Fragestellungen. In: Gesundheitsokonomie und Qualitatsmanagement. 2003 ; Vol. 8, No. 2. pp. 120-124.
Download
@article{7a0f0640e5594bb2a265d4cc76690d9c,
title = "Kosten der Schizophrenie: Strukturgleichungsmodelle als Instrument der Entscheidungshilfe bei gesundheits{\"o}konomischen Fragestellungen",
abstract = "Objective: The goal of the study is to bring out advantages of structural equation models over conventional methods in health economic decision-making processes. Methods: In this study, causal relations of direct and indirect costs are investigated in schizophrenic subjects. The structural equation models are based on data obtained from a health care analysis. X2 test, degrees of freedom, P value, goodness of fit and adjusted goodness of fit are used to evaluate the structural equation models. Results: The structural equation model demonstrates that no less than 23 percent of direct costs for the treatment of schizophrenia are accounted for by the two factors severity of disease and time. The severity of disease carries more weight than the time factor. The standardized path coefficient is 0.33. The time factor has less effect than the severity of disease with a standardized regression coefficient of 0.27. The double arrow between the factors severity and time describes a correlation which is 0.26. Based on both inference statistical and descriptive parameters, all of which are within the nominal range, the structural equation model for direct costs can be confirmed with the data set on hand. With use of this model, 51 percent of indirect costs are accounted for by the two factors severity and time. As for indirect costs, the time factor of 0.63 carries more than twice as much weight as severity exerting effects with a standardized path coefficient of 0.25. This also explains the correlation between the residuum of the Global Assessment Scale (GAS) and the residuum of the time factor. There is a relationship between the residuum of GAS, which measures the degree of severity in the long term, and the residuum of the time factor. It may be conjectured that another factor is hiding behind this correlation, that is early retirement. In this model, too, all parameters are within the nominal range. Conclusions: The example of costs of schizophrenia has demonstrated the portrayal and quantification of networking structures. Due to the portrayal of structures and quantification of causal relationships, structural equation models provide substantial support for decision-making processes.",
keywords = "Health care costs, Schizophrenia, Structural equation model",
author = "J. Clouth and A. Uber and {Graf von der Schulenburg}, {J. M.}",
year = "2003",
month = apr,
doi = "10.1055/s-2003-39145",
language = "Multiple languages",
volume = "8",
pages = "120--124",
number = "2",

}

Download

TY - JOUR

T1 - Kosten der Schizophrenie

T2 - Strukturgleichungsmodelle als Instrument der Entscheidungshilfe bei gesundheitsökonomischen Fragestellungen

AU - Clouth, J.

AU - Uber, A.

AU - Graf von der Schulenburg, J. M.

PY - 2003/4

Y1 - 2003/4

N2 - Objective: The goal of the study is to bring out advantages of structural equation models over conventional methods in health economic decision-making processes. Methods: In this study, causal relations of direct and indirect costs are investigated in schizophrenic subjects. The structural equation models are based on data obtained from a health care analysis. X2 test, degrees of freedom, P value, goodness of fit and adjusted goodness of fit are used to evaluate the structural equation models. Results: The structural equation model demonstrates that no less than 23 percent of direct costs for the treatment of schizophrenia are accounted for by the two factors severity of disease and time. The severity of disease carries more weight than the time factor. The standardized path coefficient is 0.33. The time factor has less effect than the severity of disease with a standardized regression coefficient of 0.27. The double arrow between the factors severity and time describes a correlation which is 0.26. Based on both inference statistical and descriptive parameters, all of which are within the nominal range, the structural equation model for direct costs can be confirmed with the data set on hand. With use of this model, 51 percent of indirect costs are accounted for by the two factors severity and time. As for indirect costs, the time factor of 0.63 carries more than twice as much weight as severity exerting effects with a standardized path coefficient of 0.25. This also explains the correlation between the residuum of the Global Assessment Scale (GAS) and the residuum of the time factor. There is a relationship between the residuum of GAS, which measures the degree of severity in the long term, and the residuum of the time factor. It may be conjectured that another factor is hiding behind this correlation, that is early retirement. In this model, too, all parameters are within the nominal range. Conclusions: The example of costs of schizophrenia has demonstrated the portrayal and quantification of networking structures. Due to the portrayal of structures and quantification of causal relationships, structural equation models provide substantial support for decision-making processes.

AB - Objective: The goal of the study is to bring out advantages of structural equation models over conventional methods in health economic decision-making processes. Methods: In this study, causal relations of direct and indirect costs are investigated in schizophrenic subjects. The structural equation models are based on data obtained from a health care analysis. X2 test, degrees of freedom, P value, goodness of fit and adjusted goodness of fit are used to evaluate the structural equation models. Results: The structural equation model demonstrates that no less than 23 percent of direct costs for the treatment of schizophrenia are accounted for by the two factors severity of disease and time. The severity of disease carries more weight than the time factor. The standardized path coefficient is 0.33. The time factor has less effect than the severity of disease with a standardized regression coefficient of 0.27. The double arrow between the factors severity and time describes a correlation which is 0.26. Based on both inference statistical and descriptive parameters, all of which are within the nominal range, the structural equation model for direct costs can be confirmed with the data set on hand. With use of this model, 51 percent of indirect costs are accounted for by the two factors severity and time. As for indirect costs, the time factor of 0.63 carries more than twice as much weight as severity exerting effects with a standardized path coefficient of 0.25. This also explains the correlation between the residuum of the Global Assessment Scale (GAS) and the residuum of the time factor. There is a relationship between the residuum of GAS, which measures the degree of severity in the long term, and the residuum of the time factor. It may be conjectured that another factor is hiding behind this correlation, that is early retirement. In this model, too, all parameters are within the nominal range. Conclusions: The example of costs of schizophrenia has demonstrated the portrayal and quantification of networking structures. Due to the portrayal of structures and quantification of causal relationships, structural equation models provide substantial support for decision-making processes.

KW - Health care costs

KW - Schizophrenia

KW - Structural equation model

UR - http://www.scopus.com/inward/record.url?scp=0037951445&partnerID=8YFLogxK

U2 - 10.1055/s-2003-39145

DO - 10.1055/s-2003-39145

M3 - Article

AN - SCOPUS:0037951445

VL - 8

SP - 120

EP - 124

JO - Gesundheitsokonomie und Qualitatsmanagement

JF - Gesundheitsokonomie und Qualitatsmanagement

SN - 1432-2625

IS - 2

ER -